Zobrazeno 1 - 10
of 63
pro vyhledávání: ''
Autor:
Francisco García-del Portillo, Amparo Cano, Pierre Dubus, Alberto Vázquez-Naharro, Celia López-Menéndez, Marisa M. Faraldo, Vanesa Santos, Patricia G. Santamaría, Gema Moreno-Bueno, Ángel Martínez-Ramírez
Publikováno v:
Cancer Research
Cancer Research, American Association for Cancer Research, 2021, 81 (17), pp.4529-4544. ⟨10.1158/0008-5472.can-20-2685⟩
Cancer Res
Digital.CSIC. Repositorio Institucional del CSIC
instname
Cancer Research, 2021, 81 (17), pp.4529-4544. ⟨10.1158/0008-5472.can-20-2685⟩
Cancer Research, American Association for Cancer Research, 2021, 81 (17), pp.4529-4544. ⟨10.1158/0008-5472.can-20-2685⟩
Cancer Res
Digital.CSIC. Repositorio Institucional del CSIC
instname
Cancer Research, 2021, 81 (17), pp.4529-4544. ⟨10.1158/0008-5472.can-20-2685⟩
© 2021 The Authors.
Cancer stem cells (CSC) are considered responsible for tumor initiation, therapeutic resistance, and metastasis. A comprehensive knowledge of the mechanisms governing the acquisition and maintenance of cancer stemness is cru
Cancer stem cells (CSC) are considered responsible for tumor initiation, therapeutic resistance, and metastasis. A comprehensive knowledge of the mechanisms governing the acquisition and maintenance of cancer stemness is cru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3a4a0a66c04aa2325760aad00d69a94
https://hal.sorbonne-universite.fr/hal-03353734/document
https://hal.sorbonne-universite.fr/hal-03353734/document
Autor:
Marie-Ange Mouret-Reynier, Véronique D'Hondt, Audrey Mailliez, Gaëtane Simon, Damien Parent, Silvia Ilie, N. Madranges, Christelle Levy, David Pérol, Gaëlle Chenuc, Pierre Heudel, Thomas Vermeulin, Lionel Uwer, Paule Augereau, Thierry Petit, Suzette Delaloge, Florence Dalenc, Christophe Perrin, Etienne Brain, Jean-Sebastien Frenel, Anthony Gonçalves, Jean-Christophe Eymard, Jean-Marc Ferrero, Mathieu Robain, Marie-Paule Sablin
Publikováno v:
Anticancer Research
Anticancer Research, International Institute of Anticancer Research, 2020, 40 (7), pp.3905-3913. ⟨10.21873/anticanres.14381⟩
Anticancer Research, International Institute of Anticancer Research, 2020, 40 (7), pp.3905-3913. ⟨10.21873/anticanres.14381⟩
Background/aim Vinorelbine is indicated for use in the treatment of MBC as a single agent or in combination but there is little real world data on this molecule and even less on its oral form. We exploited the Unicancer Epidemiology Strategy Medical-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::617a1f7090bc6531688599f52d2e7eb4
https://hal.archives-ouvertes.fr/hal-02995541
https://hal.archives-ouvertes.fr/hal-02995541
Autor:
Thierry Fest, Delphine Topart, Catherine Alix-Panabières, Thierry Maudelonde, Martine Mazel, Kai Bartkowiak, Laure Cayrefourcq, Klaus Pantel, William Jacot, Delphine Rossille
Publikováno v:
Molecular Oncology
Molecular Oncology, 2015, 9 (9), pp.1773-1782. ⟨10.1016/j.molonc.2015.05.009⟩
Molecular Oncology, Elsevier, 2015, 9 (9), pp.1773-1782. ⟨10.1016/j.molonc.2015.05.009⟩
Molecular Oncology, 2015, 9 (9), pp.1773-1782. ⟨10.1016/j.molonc.2015.05.009⟩
Molecular Oncology, Elsevier, 2015, 9 (9), pp.1773-1782. ⟨10.1016/j.molonc.2015.05.009⟩
International audience; Immune checkpoint regulators such as PD-L1 have become exciting new therapeutic targets leading to long lasting remissions in patients with advanced malignancies. However, in view of the remarkable costs and the toxicity profi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::131ac6d9355a86bf2622e6f33f3cdfa7
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01162382
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01162382
Autor:
Pierre-Marie Martin, Chafika Mazouni, Pascal Bonnier, Frédéric Fina, L’houcine Ouafik, Sylvie Romain
Publikováno v:
Journal of Cancer Research and Clinical Oncology
Journal of Cancer Research and Clinical Oncology, Springer Verlag, 2015, 141 (6), pp.1083-1088. ⟨10.1007/s00432-014-1889-7⟩
Journal of Cancer Research and Clinical Oncology, 2015, 141 (6), pp.1083-1088. ⟨10.1007/s00432-014-1889-7⟩
Journal of Cancer Research and Clinical Oncology, Springer Verlag, 2015, 141 (6), pp.1083-1088. ⟨10.1007/s00432-014-1889-7⟩
Journal of Cancer Research and Clinical Oncology, 2015, 141 (6), pp.1083-1088. ⟨10.1007/s00432-014-1889-7⟩
International audience; PURPOSE: To develop a prognostic nomogram to predict freedom from recurrence for patients treated with adjuvant hormonal therapy (HT) for localised breast cancer (BC).METHODS: We performed a retrospective analysis of 142 patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e36fec7da5a7067bc64441c91f26afd
https://hal-amu.archives-ouvertes.fr/hal-01480127
https://hal-amu.archives-ouvertes.fr/hal-01480127
Autor:
Pierre Laurent-Puig, Pierre Kerbrat, Benoit Liquet, Sylvia Richardson, Pascal Guénel, Patrick Arveux, Thérèse Truong, Claire Mulot, Emilie Cordina-Duverger, Marie Sanchez, Florence Menegaux, Sabine Plancoulaine
Publikováno v:
Endocrine-Related Cancer
Endocrine-Related Cancer, BioScientifica, 2014, pp.10
HAL
Endocrine-Related Cancer, BioScientifica, 2014, pp.10
HAL
Night shift work has been associated with an increased risk of breast cancer pointing to a role of circadian disruption. We investigated the role of circadian clock gene polymorphisms and their interaction with nightwork in breast cancer risk in a po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc2026455101e3d1573526117d5eeb02
https://hal.inria.fr/hal-01097160
https://hal.inria.fr/hal-01097160
Autor:
Luis Ubillos, Claude Leclerc, Otto Pritsch, Andrea Medeiros, Sylvie Bay, Christelle Ganneau, Gonzalo Obal, Eduardo Osinaga, Richard Lo-Man, Mariela Bollati-Fogolín, Nora Berois, Edith Dériaud, Daniel Mazal
Publikováno v:
Cancer Immunology, Immunotherapy
Cancer Immunology, Immunotherapy, 2013, 62 (6), pp.1107-22. ⟨10.1007/s00262-013-1425-7⟩
Cancer Immunology, Immunotherapy, Springer Verlag, 2013, 62 (6), pp.1107-22. ⟨10.1007/s00262-013-1425-7⟩
Cancer Immunology, Immunotherapy, 2013, 62 (6), pp.1107-22. ⟨10.1007/s00262-013-1425-7⟩
Cancer Immunology, Immunotherapy, Springer Verlag, 2013, 62 (6), pp.1107-22. ⟨10.1007/s00262-013-1425-7⟩
International audience; The Tn antigen (GalNAcα-O-Ser/Thr) is a well-established tumor-associated marker which represents a good target for the design of anti-tumor vaccines. Several studies have established that the binding of some anti-Tn antibodi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::daa9b24b0ad1ba665c237afc07901a94
https://hal-riip.archives-ouvertes.fr/pasteur-00847180
https://hal-riip.archives-ouvertes.fr/pasteur-00847180
Autor:
Cédric de Bazelaire, Anne de Roquancourt, Marcela Albiter, Solenne Leman-Detours, Patricia de Cremoux, Jacqueline Lehmann-Che, Anne Janin, Marc Espié, E. Bourstyn, Raphaël Porcher, Anne-Sophie Hamy, Laurence Cahen-Doidy, Fatiha Bouhidel, Caroline Cuvier, Hanadi Habuellelah, Sylvie Giacchetti, Marc Barritault, Philippe Bertheau
Publikováno v:
Breast Cancer Research
Breast Cancer Research, 2013, 15 (3), pp.R37. ⟨10.1186/bcr3421⟩
Breast Cancer Research : BCR
Breast Cancer Research, BioMed Central, 2013, 15 (3), pp.R37. ⟨10.1186/bcr3421⟩
Breast Cancer Research, 2013, 15 (3), pp.R37. ⟨10.1186/bcr3421⟩
Breast Cancer Research : BCR
Breast Cancer Research, BioMed Central, 2013, 15 (3), pp.R37. ⟨10.1186/bcr3421⟩
International audience; INTRODUCTION: Molecular apocrine (MA) tumors are estrogen receptor (ER) negative breast cancers characterized by androgen receptor (AR) expression. We analyzed a group of 58 transcriptionally defined MA tumors and proposed a n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d14c98e5d4f5cba185019e16fe27f2d7
https://www.hal.inserm.fr/inserm-00850498/document
https://www.hal.inserm.fr/inserm-00850498/document
Autor:
Karin Peignaux, Hans H. Storm, Milena Sant, Paolo Baili, Michel Velten, Michel P Coleman, Chakameh Safaei Diba, Sabine Siesling, Marc Colonna, Tiefu Shen, Ana Torrella-Ramos, Paolo Contiero, Rosemary D. Cress, Claudia Cirilli, Susan Bolick, Per-Uno Malmström, Adele Traina, Laufey Tryggvadottir, John P Fulton, Lisa C. Richardson, Maja Primic-Žakelj, María José Sánchez, M. Isabel Izarzugaza, Holly J. Wolf, Adri C. Voogd, Franco Berrino, Anne Sophie Woronoff, Hannah K. Weir, Timo Hakulinen, Jadwiga Rachtan, Tiiu Aareleid, Pascale Grosclaude, Maria J. Schymura, Claudia Allemani, Marina Vercelli, Magdalena Bielska-Lasota, Emanuele Crocetti, Eva Ardanaz, Xiao-Cheng Wu, Rosario Tumino
Publikováno v:
International Journal of Cancer
International Journal of Cancer, Wiley, 2013, 132 (5), pp.1170-1181. ⟨10.1002/ijc.27725⟩
International Journal of Cancer, 132(5), 1170-1181. Wiley
International Journal of Cancer, Wiley, 2013, 132 (5), pp.1170-1181. 〈10.1002/ijc.27725〉
International Journal of Cancer, Wiley, 2013, 132 (5), pp.1170-1181. ⟨10.1002/ijc.27725⟩
International Journal of Cancer, 132(5), 1170-1181. Wiley
International Journal of Cancer, Wiley, 2013, 132 (5), pp.1170-1181. 〈10.1002/ijc.27725〉
International audience; Breast cancer survival is reportedly higher in the US than in Europe. The first worldwide study (CONCORD) found wide international differences in age-standardized survival. The aim of this study is to explain these survival di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8bcf625a87a153072b9a3fa025df102
https://hal.archives-ouvertes.fr/hal-00771940
https://hal.archives-ouvertes.fr/hal-00771940
Autor:
Idil I. Aigha, Hager Memmi, Lotfi Chouchane, Wijden Mahfoudh, Noureddine Bouaouina, Jingxuan Shan, Sonia Abdelhak, Sallouha Gabbouj, Elham Hassen, Rebecca Mathew, Ahlem Benhadjayed, Yassmine Remadi, Shoba P Dsouza
Publikováno v:
Breast Cancer Research and Treatment
Breast Cancer Research and Treatment, Springer Verlag, 2012, 135 (3), pp.715-24. ⟨10.1007/s10549-012-2202-6⟩
Breast Cancer Research and Treatment, Springer Verlag, 2012, 135 (3), pp.715-24. ⟨10.1007/s10549-012-2202-6⟩
Genome-wide Association Studies (GWAS) revealed novel genetic markers for breast cancer susceptibility. But little is known about the risk factors and molecular events associated with breast cancer in Arab Population. Therefore, we designed a broad s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffcde7c174fe2b743da2d13d0da814e0
https://hal-riip.archives-ouvertes.fr/pasteur-01375153
https://hal-riip.archives-ouvertes.fr/pasteur-01375153
Autor:
Sandrine Boyault, Thomas Bachelot, Alain Puisieux, Christine Lasset, Claudine Navarro, Isabelle Treilleux, Youenn Drouet, Eric Tabone, Qing Wang
Publikováno v:
Breast Cancer Research and Treatment
Breast Cancer Research and Treatment, 2012, 132 (1), pp.29-39. ⟨10.1007/s10549-011-1518-y⟩
Breast Cancer Research and Treatment, Springer Verlag, 2012, 132 (1), pp.29-39. ⟨10.1007/s10549-011-1518-y⟩
Breast Cancer Research and Treatment, Springer Verlag, 2012, 132 (1), pp.29-39. 〈10.1007/s10549-011-1518-y〉
Breast Cancer Research and Treatment, 2012, 132 (1), pp.29-39. ⟨10.1007/s10549-011-1518-y⟩
Breast Cancer Research and Treatment, Springer Verlag, 2012, 132 (1), pp.29-39. ⟨10.1007/s10549-011-1518-y⟩
Breast Cancer Research and Treatment, Springer Verlag, 2012, 132 (1), pp.29-39. 〈10.1007/s10549-011-1518-y〉
International audience; Understanding how cancer genes are mutated in individual tumors is an important issue with potential clinical and therapeutic impact. This is especially relevant with recently developed targeted therapies since mutated genes c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e5b6f5045da96168a711c980d8f7e00
https://hal.science/hal-01007700
https://hal.science/hal-01007700